Pharmakonzern · Vereinigte Staaten
Pfizer
Ein Konzern aus 190 Unternehmen: 3.955 Arzneimittel, verteilt auf 12 Länder.
Konzernstruktur
190 Unternehmen, verteilt auf 32 Länder
Wird geladen …
Pharmakonzern · Vereinigte Staaten
Ein Konzern aus 190 Unternehmen: 3.955 Arzneimittel, verteilt auf 12 Länder.
190 Unternehmen, verteilt auf 32 Länder
Ein kostenloses Konto für die Prognia-Apps: Ward zum Lernen, Osler für klinische Antworten mit ihren Quellen und das Netzwerk, um deine Kolleginnen und Kollegen zu finden.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Alle Arzneimittel aller Unternehmen im Konzern, aktuelle zuerst.
1–25 von 3.955
| Arzneimittel | Wirkstoff | Land | Status | Zulassung |
|---|---|---|---|---|
| A-HYDROCORT100mg base/vial | 1gm base/vial | 250mg base/vial | 500mg base/vial · Injectable | Hydrocortisone | Vereinigte Staaten | Nicht im Handel | 1978 |
| A-METHAPRED125mg base/vial | 1gm base/vial | 40mg base/vial | 500mg base/vial · Injectable | Methylprednisolone | Vereinigte Staaten | Nicht im Handel | 1978 |
| ABRILADA10mg/0.2ml | 20mg/0.4ml | 40mg/0.8ml · Injectable | Adalimumab | Vereinigte Staaten | Im Handel | 2019 |
| Abrilada40mg/0.8ml · Injection | Adalimumab | Vereinigte Staaten | Im Handel | 2019 |
| ABRILADA40 mg / 0.8 ml · Solution | Adalimumab | Kanada | Im Handel | 2022 |
| Abrilada10mg/0.2ml · Injection | Adalimumab | Vereinigte Staaten | Nicht im Handel | 2019 |
| ABRILADA40 mg / 0.8 ml · Kit, Solution | Adalimumab | Kanada | Zugelassen | |
| ABRILADA10 mg / 0.2 ml · Solution | Adalimumab | Kanada | Zugelassen | |
| ABRILADA40 mg / 0.8 ml · Solution | Adalimumab | Kanada | Im Handel | 2022 |
| ABRILADA20 mg / 0.4 ml · Solution | Adalimumab | Kanada | Im Handel | 2023 |
| ABRILADA SOLUTION FOR INJECTION IN SINGLE-DOSE PREFILLED PEN 40 MG/0.8 ML40mg/0.8ml · Injection, solution | Adalimumab | Singapur | Zugelassen | 2022 |
| ABRYSVO | Vacina vírus sincicial respiratório a e b | Brasilien | Zugelassen | 2024 |
| Abrysvo | Respiratory syncytial virus vaccines | EU (EMA) | Zugelassen | 2023 |
| Abrysvo120ug · Injection | Respiratory syncytial virus vaccines | Vereinigte Staaten | Im Handel | 2023 |
| ABRYSVO60 mcg / 0.5 ml + 60 mcg / 0.5 ml · Kit, Powder For Solution | Rsv subgroup a stabilized prefusion f protein, Rsv subgroup b stabilized prefusion f protein | Kanada | Im Handel | 2024 |
| Abrysvo poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Recombinant respiratoir syncytieel virus subgroep a prefusie f antigeen, Recombinant respiratoir syncytieel virus subgroep b prefusie f antigeen | Niederlande | Zugelassen | 2023 |
| Abrysvo poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Recombinant respiratoir syncytieel virus subgroep a prefusie f antigeen, Recombinant respiratoir syncytieel virus subgroep b prefusie f antigeen | Niederlande | Zugelassen | 2023 |
| ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE0,06 mg + 0,06 mg · Polvo y disolvente para solución inyectable | Virus sincitial respiratorio, subgroupo a, subunidad f proteina estabilizada en prefusion, Virus sincitial respiratorio, subgroupo b, subunidad f proteina estabilizada en prefusion | Spanien | Im Handel | 2023 |
| ABRYSVO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION0.06 mg/vial + 0.06 mg/vial · Injection, powder, for solution | Rsv subgroup a stabilized prefusion f protein, Rsv subgroup b stabilized prefusion f protein | Singapur | Zugelassen | 2024 |
| ACCUPRIL10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG BASE * · Tablet | Quinapril | Vereinigte Staaten | Nicht im Handel | 1991 |
| ACCURETIC12.5MG; 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 12.5MG; 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG; 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness · Tablet | Hydrochlorothiazide, Quinapril | Vereinigte Staaten | Nicht im Handel | 1999 |
| Aciclovir Hospira 25 mg/ml, concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie | Aciclovir | Niederlande | Zugelassen | 1999 |
| ADCETRIS50 mg / vial · Powder For Solution | Brentuximab vedotin | Kanada | Im Handel | 2013 |
| ADRIAMYCIN PFS2 mg / ml · Solution | Doxorubicin | Kanada | Nicht im Handel | 1995 |
| ADRIAMYCIN PFS200mg/100ml | 2mg/ml · Injectable | Doxorubicin | Vereinigte Staaten | Nicht im Handel | 1991 |
Wo es Zulassungen hält oder Arzneimittel herstellt, und wie viele davon aktuell sind.
| Land | Arzneimittel | Aktuell | Früher | Unternehmen |
|---|---|---|---|---|
| Kanada | 1.083 | 278 | 805 | UnternehmenAlle Arzneimittel |
| Vereinigte Staaten | 648 | 643 | 5 | UnternehmenAlle Arzneimittel |
| Brasilien | 516 | 85 | 431 | UnternehmenAlle Arzneimittel |
| Saudi-Arabien | 444 | 444 | 0 | UnternehmenAlle Arzneimittel |
| Spanien | 370 | 311 | 59 | UnternehmenAlle Arzneimittel |
| Rumänien | 241 | 0 | 241 | UnternehmenAlle Arzneimittel |
| Niederlande | 221 | 221 | 0 | UnternehmenAlle Arzneimittel |
| Singapur | 165 | 165 | 0 | UnternehmenAlle Arzneimittel |
| Serbien | 117 | 111 | 6 | UnternehmenAlle Arzneimittel |
| Europäische Union (EMA) | 96 | 56 | 40 | UnternehmenAlle Arzneimittel |
| Kroatien | 49 | 49 | 0 | UnternehmenAlle Arzneimittel |
| Kolumbien | 5 | 0 | 5 | UnternehmenAlle Arzneimittel |
Auch registriert in: Australien, Deutschland, Frankreich, Italien, Malaysia, Schweden, Vereinigtes Königreich
Die ATC-Gruppen, zu denen die meisten seiner Arzneimittel gehören, größte zuerst.
Die Wirkstoffe in den meisten seiner Arzneimittel.
Wie die Register den Namen schreiben, normalisiert: ohne Rechtsform, Akzente und Großbuchstaben.
Von Prognia aus den unten genannten öffentlichen Arzneimittel- und Unternehmensregistern zusammengestellt. Logos werden nicht verwendet.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Source: European Medicines Agency (EPAR data).
Lizenz: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Lizenz: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Lizenz: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Lizenz: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Lizenz: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Lizenz: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Lizenz: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Lizenz: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros, dataset spzp-dfuc, rowsUpdatedAt 1792152828, acquired 2026-10-26; original values retained.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos, dataset vwwf-4ftk, rowsUpdatedAt 1792152641, acquired 2026-10-26; original values retained.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Lizenz: CC BY-SA 4.0
Bundesinstitut für Arzneimittel und Medizinprodukte, pediatric list, acquired 2026-10-29T14:36:58.614273+00:00
Lizenz: commercial redistribution permission not established
Bundesinstitut für Arzneimittel und Medizinprodukte, urgent list, acquired 2026-10-29T14:36:58.856157+00:00
Lizenz: commercial redistribution permission not established
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.
Lizenz: commercial redistribution permission not established
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
Companies House, Find and update company information; exact company number and page URL, accessed 8 October 2026. Structured factual extraction by Prognia. Crown-created website material under OGL 3.0: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Lizenz: Companies House statutory public-register use; OGL 3.0 for Crown-created website material
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; Crown copyright MHRA factual register
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Lizenz: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
GLEIF; exact source URL and retrieval date; no endorsement.
Lizenz: CC0
Companies Registry, Government of the Hong Kong Special Administrative Region, via DATA.GOV.HK; exact dataset/resource URL, original CSV URL, retrieval date, and notice of selection/normalization by Prognia; no endorsement.
Lizenz: DATA.GOV.HK Terms of Use
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Lizenz: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Lizenz: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Lizenz: Italian Open Data Licence
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Lizenz: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Lizenz: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Lizenz: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Lizenz: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Saudi Food and Drug Authority (SFDA), local human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Lizenz: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Lizenz: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Lizenz: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Lizenz: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Fehler melden oder Entfernung beantragenKorrekturen vom Unternehmen selbst sind willkommen.
Halten Sie die Arzneimittel von Pfizer auf Prognia korrekt, sehen Sie, wie Fachleute sie nutzen, und beantworten Sie ihre Fragen. Ein 20-minütiges Gespräch, auf Englisch.
Gespräch buchenBekannte Pharmakonzerne, jeweils mit allen Unternehmen.
Nach der Zahl ihrer Arzneimittel geordnet.